A growing number of studies suggest that NF-κB polymorphisms are related to many immunity-associated diseases, such as hepatocellular carcinoma29, colorectal cancer30, chronic hepatitis C and liver disease progression31, rheumatoid arthritis32, asthma33 as well as other diseases13–20. Here, NFKB1 is linked to liver disorder.